Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/127843
Título: Discovery, molecular modeling and biological evaluation of 1,3,5-triaril-pyrazole derivates as novel Estrogen Receptor Modulators
Autores/as: López Rojas, Priscila
Amesty, Ángel
Fernández Sánchez, Yeray
Guerra Rodríguez, Miguel
Santana Viera, Sergio 
Recio Cruz, Carlota Pilar 
Guerra Hernández, Carlos Borja 
Estévez Braun,Ana 
Fernández Pérez, Leandro Fco 
Clasificación UNESCO: 3209 Farmacología
Palabras clave: Estrogens
Biological evaluation
Fecha de publicación: 2023
Editor/a: British Pharmacological Society
Conferencia: 19th World Congress of Basic and Clinical Pharmacology 
Resumen: The biological actions of estrogens are mediated by estrogen binding to one of two specific estrogen receptors (ERs), ERαand ERβ. The ERs,which belong to the nuclear receptor superfamily of ligand-regulated transcription factors, are products of different genes and exhibit tissue- andcell-type specific expression. Clinically relevant, ERs are currently considered relevant drug targets for prevention and/or treatment of several dis-eases (from cancer, metabolic and cardiovascular, inflammation, and osteoporosis to neurodegeneration). In this work, new derivatives of1,3,5-triaril-pyrazoles were designed, synthesized and evaluated in vitro as Estrogen Receptor Modulators.
URI: http://hdl.handle.net/10553/127843
ISSN: 0007-1188
Fuente: Brithis Journal of Pharmacology [ISSN 0007-1188, eISSN 1476-5381 ], v. 180 (1), p. 580-581, (Julio 2023)
Colección:Póster de congreso
Vista completa

Visitas

65
actualizado el 12-may-2024

Google ScholarTM

Verifica


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.